| Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy Y Huang, J Yuan, E Righi, WS Kamoun, M Ancukiewicz, J Nezivar, ... Proceedings of the National Academy of Sciences 109 (43), 17561-17566, 2012 | 941 | 2012 |
| Modeling the onset of symptoms of COVID-19 JR Larsen, MR Martin, JD Martin, P Kuhn, JB Hicks Frontiers in public health, 473, 2020 | 264 | 2020 |
| TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity M Panagi, C Voutouri, F Mpekris, P Papageorgis, MR Martin, JD Martin, ... Theranostics 10 (4), 1910, 2020 | 130 | 2020 |
| Quantum dot/antibody conjugates for in vivo cytometric imaging in mice HS Han, E Niemeyer, Y Huang, WS Kamoun, JD Martin, J Bhaumik, ... Proceedings of the National Academy of Sciences 112 (5), 1350-1355, 2015 | 129 | 2015 |
| Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumor microenvironment JD Martin, M Panagi, C Wang, TT Khan, MR Martin, C Voutouri, K Toh, ... ACS nano 13 (6), 6396-6408, 2019 | 103 | 2019 |
| Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant JR Larsen, MR Martin, JD Martin, JB Hicks, P Kuhn PLOS Computational Biology 17 (12), e1009629, 2021 | 26 | 2021 |
| Mining and forecasting career trajectories of music artists S Arakelyan, F Morstatter, M Martin, E Ferrara, A Galstyan Proceedings of the 29th on Hypertext and Social Media, 11-19, 2018 | 16 | 2018 |
| Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition JD Martin, RM Lanning, VP Chauhan, MR Martin, AS Mousa, WS Kamoun, ... Clinical Cancer Research 28 (14), 3076-3090, 2022 | 5 | 2022 |
| Molecular structure discovery for untargeted metabolomics using biotransformation rules and global molecular networking M Martin, W Bittremieux, S Hassoun bioRxiv, 2024.02. 04.578795, 2024 | | 2024 |
John MartinMateria TherapeuticsVerified email at mit.edu
